Clinical Trials
2 trialsNCT06275919 2026-05-13
MIRAGE
Istituto Oncologico Veneto IRCCS
Phase 2 Recruiting
NCT05907057 2026-05-08
An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
Servier
Phase 3 Recruiting